About
the VA Greater Los Angeles Healthcare System (GLA). . .
GLA is the largest,
most complex healthcare system within the Department
of Veterans Affairs. It is one component of the VA Desert Pacific
Healthcare Network (VISN22) offering services to veterans residing in
Southern California and Southern Nevada. GLA consists of 3 ambulatory
care centers, a tertiary care facility and 10 community based outpatient
clinics. GLA serves veterans residing throughout five counties: Los Angeles,
Ventura, Kern, Santa Barbara, and San Luis Obispo. There are 1.4 million
veterans in the GLA service area. GLA is affiliated with both UCLA School
of Medicine and USC School of Medicine, as well as more than 45 colleges,
universities and vocational schools in 17 different medical, nursing,
paramedical and administrative programs.
Mission:
"To serve the
healthcare needs of America's veterans with dignity and compassion."
Vision:
"To be the
preferred healthcare provider for veterans by exceeding their expectations,
and being recognized for quality care, innovation and value."
Values:
"We value trust, respect, excellence, commitment and compassion."
Goals:
- Goal 1: Enhance
Clinical Quality Outcomes/Patient Safety
- Goal 2: Improve
Coordination of Care/Integrated Healthcare System
- Goal 3: Maximize
Employee Potential and Team Synergy
- Goal 4: Increase/Enhance
Market Share/Users
Accomplishments:
GLA has
a rich history in innovation that includes the conceptual design of the
CT scan by Dr. William Oldendorf a former Senior Medical Investigator
at Brentwood. VA Wadsworth is known for the establishment of the first
Dialysis unit in Southern California and the second chronic dialysis unit
West of the Mississippi by Dr. Milton Rubini. Another first attributed
to research history was made by Dr. Jack Coburn who was the first to delineate
a clinical test to determine aluminum-related bone disease in dialysis
patients which is used world-wide to identify this clinical problem. Dr.
George Sachs was instrumental in the design and basic cell biological
testing of the now widely used proton pump blockers for peptic ulcer disease.
Dr. Sydney Finegold is a world-renowned authority on the biology and taxonomy
of anaerobic bacteria and has contributed significantly to the knowledge
of these disease-producing organisms. To date, GLA has had three recipients
of the Middleton Award, which is the highest award in the VA recognizing
outstanding research contributions: Dr. George Sachs, Dr. Jack Coburn,
and Dr. Sydney Finegold.
Currently, ongoing
research at the WLA site encompasses investigations of newer therapies
for schizophrenia and substance abuse disorders, investigations of the
pathogenesis and therapy for cancers such as lung, prostate and gastrointestinal
tract, AIDS, and aging disorders. The Sepulveda site has concentrated
on the study and treatment of epilepsy, sleep disorders, the molecular
mechanisms of blood pressure regulation, memory disorders such as Alzheimers
disease and health delivery, access and provider behavior studies.
Center of Excellence:
- Homeless
Center of Excellence
- Center for the
Study of Healthcare Provider Behavior-VA HSR&D Center of Excellence
- Parkinson's Disease
Research Center
2003 |